Point mutation in essential genes with loss or mutation of the second allele: relevance to the retention of tumor-specific antigens.
about
Mutant alpha-actinin-4 promotes tumorigenicity and regulates cell motility of a human lung carcinomaThe response of autologous T cells to a human melanoma is dominated by mutated neoantigensMany ribosomal protein genes are cancer genes in zebrafishRPL41, a small ribosomal peptide deregulated in tumors, is essential for mitosis and centrosome integrity.A novel approach to biomarker discovery in head and neck cancer using an autoantibody signature.Negative regulation of HDM2 to attenuate p53 degradation by ribosomal protein L26.Genetic changes occurring in established tumors rapidly stimulate new antibody responsesProgression of cancer from indolent to aggressive despite antigen retention and increased expression of interferon-gamma inducible genesImmunotherapy of cytotoxic T cell-resistant tumors by T helper 2 cells: an eotaxin and STAT6-dependent process.Tumor-infiltrating T lymphocytes: friends or foes?Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors.Targeting cancer-specific mutations by T cell receptor gene therapy.Tumor Microenvironment as a New Target for Tumor Immunotherapy of Polysaccharides.'Final common pathway' of human cancer immunotherapy: targeting random somatic mutations.Nucleolar trafficking of the mouse mammary tumor virus gag protein induced by interaction with ribosomal protein L9.Combined immunotherapy with Listeria monocytogenes-based PSA vaccine and radiation therapy leads to a therapeutic response in a murine model of prostate cancer.Ribosomal versus non-ribosomal cellular antigens: factors determining efficiency of indirect presentation to CD4+ T cells.Antigenic drift as a mechanism for tumor evasion of destruction by cytolytic T lymphocytesGetting personal with neoantigen-based therapeutic cancer vaccines.Eradication of Large Solid Tumors by Gene Therapy with a T-Cell Receptor Targeting a Single Cancer-Specific Point Mutation.Transfer of Allogeneic CD4+ T Cells Rescues CD8+ T Cells in Anti-PD-L1-Resistant Tumors Leading to Tumor Eradication.The ribosome, (slow) beating heart of cancer (stem) cell.
P2860
Q24321856-E9E35A1A-21CB-4216-AE68-7E6D315A9AA4Q24535034-138D73C5-1FF1-4C2A-B7F7-C06005C27452Q24796901-9616D3C9-A659-4B40-8824-C7B220FDF3EBQ33727053-59209544-A9E1-479A-AAC0-246CF2F91FB2Q33851750-DDF1A410-77C2-490C-AC48-8A0DA9512F6AQ34246768-C49F0CD6-D81E-45AE-8C12-C91EE9B93255Q34983184-0C498451-7782-4A81-AC33-4DAB1DCCC03BQ35079913-4CF106CD-4009-4A04-9D24-C8BF82132078Q36370554-A80A1ED9-99C5-4621-AADA-A22F2BED9C10Q36381918-F984A5FE-1078-4FD8-8F0F-0E481CC4BE15Q36402716-96857926-4772-40FD-ADB7-982BF5523272Q38366556-4FA103EE-C19B-433F-8C44-4BE637588B4CQ38606460-BEEDA07D-9B29-4EC5-8C1C-67415583701AQ39136403-3B21D2C1-9AB3-4E5E-8C7E-A7F54EFD9B8EQ39248067-AF9A10B5-A096-4910-BFA9-F6E67F52CD71Q39340402-0330FB5A-8D4B-423C-AEBC-AD6C31412C99Q39724285-6A577AB5-F2F6-453B-BC8D-45F2A95558DAQ39752699-9A709D19-3853-4877-B93F-C3E34B592277Q39945813-DAD4E57C-2737-47F9-9768-F07BDEB0F7B1Q42573824-65FEA92C-D405-49BC-8EF3-BB861DC8EBADQ50957786-1C67DF33-C060-46F9-B817-DE53AB803DC6Q52315005-D589068E-A1C9-4612-8BC6-CAC332EC821C
P2860
Point mutation in essential genes with loss or mutation of the second allele: relevance to the retention of tumor-specific antigens.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Point mutation in essential ge ...... on of tumor-specific antigens.
@ast
Point mutation in essential ge ...... on of tumor-specific antigens.
@en
type
label
Point mutation in essential ge ...... on of tumor-specific antigens.
@ast
Point mutation in essential ge ...... on of tumor-specific antigens.
@en
prefLabel
Point mutation in essential ge ...... on of tumor-specific antigens.
@ast
Point mutation in essential ge ...... on of tumor-specific antigens.
@en
P2093
P2860
P356
P1476
Point mutation in essential ge ...... on of tumor-specific antigens.
@en
P2093
G B Beck-Engeser
H Schreiber
K Schreiber
M M Le Beau
P A Monach
R Espinosa
S C Meredith
S Wanderling
P2860
P304
P356
10.1084/JEM.194.3.285
P407
P577
2001-08-01T00:00:00Z